Adam Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 32 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 50.13%
- Profit Growth 109.89%
- Ebitda 12.22%
- Net Worth 3.09%
- Total Assets -44.70%
About Adam Laboratories
Adam Laboratories Private Limited (ALPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 March 1992 and has a history of 32 years and 11 months. Its registered office is in Uttar Pradesh, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Praveen Kapoor and Pradeep Kapoor serve as directors at the Company.
Company Details
- Location
Uttar Pradesh, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24232UP1992PTC014167
- Company No.
014167
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Mar 1992
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Adam Laboratories?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pradeep Kapoor  | Managing Director | 12-Mar-1992 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Praveen Kapoor | Director | 12-Mar-1992 | Current |
Financial Performance of Adam Laboratories.
Adam Laboratories Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 50.13% increase. The company also saw a substantial improvement in profitability, with a 109.89% increase in profit. The company's net worth moved up by a moderate rise of 3.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Adam Laboratories?
In 2023, Adam Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Medicine Distributors Private LimitedPraveen Kapoor and Pradeep Kapoor are mutual person
Chemidoc Enterprises Private LimitedPraveen Kapoor and Pradeep Kapoor are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Adam Laboratories?
Unlock and access historical data on people associated with Adam Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Adam Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Adam Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.